Search the Newsreel

Ceragon Networks Ltd (CRNT) (Q2 2026) Earnings Call Highlights: Record Bookings and Strategic ...

Ceragon Networks Ltd (CRNT) reported strong Q2 2026 results with a 14% revenue increase and record first-half bookings, driven by demand in India and a favorable competitive landscape. Despite this, the company faced challenges with declining gross margins due to product mix and supply …

trivago N.V. (TRVG) director exercises 37,733 options, sells equal ADS stake

trivago N.V. director Joana Carena Breidenbach exercised stock options for 37,733 American Depositary Shares (ADSs) at €0.3000 per ADS-equivalent on August 7 and 10, 2026. She subsequently sold all 37,733 ADSs in two blocks at prices of $5.7411 and $5.1605 per ADS. One ADS …

Silence Therapeutics' Divesiran Data Support Best-in-Class Potential, Morgan Stanley Says

Silence Therapeutics' (SLN) Phase 2 results for divesiran in polycythemia vera showed stronger activ PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a …

Chicago Atlantic Real Estate Finance Q2 Earnings Call Highlights

Key Points Interested in Chicago Atlantic Real Estate Finance, Inc.? Here are five stocks we like better. Distributable earnings fell short of the dividend: Second-quarter earnings were $0.44 per share versus a $0.47 dividend, mainly because $16.3 million of prepaid loans was redeployed later …

Chicago Atlantic Q2 2026 slides: strong portfolio amid earnings miss

Chicago Atlantic Real Estate Finance (REFI) reported an earnings miss for Q2 2026, with distributable earnings of $0.43 per share against a $0.47 forecast, primarily due to loan prepayments impacting capital redeployment. Despite this, the company highlighted a strong, diversified loan portfolio of $453.1 …

Paragon Banking Group Advances £50m Buyback, Updates Voting Share Count

Chicago Atlantic Real Estate Finance, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:REFI)

This article presents the slide deck published by Chicago Atlantic Real Estate Finance, Inc. in conjunction with their Q2 2026 earnings call. The company's earnings call presentation provides detailed financial results and operational updates for the quarter. The information is intended for investors and …

Chicago Atlantic Real Estate Finance, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:REFI) 2026-08-11

This article presents the slide deck published by Chicago Atlantic Real Estate Finance, Inc. in conjunction with their Q2 2026 earnings call. The company's earnings call presentation provides detailed financial results and operational updates for the quarter. The information is intended for investors and …

Earnings call transcript: Chicago Atlantic REFI misses Q2 2026 estimates

Ceragon Networks (NASDAQ:CRNT) Posts Quarterly Earnings Results

Chicago Atlantic Real Estate Finance (NASDAQ:REFI) Releases Earnings Results, Misses Estimates By $0.05 EPS

Chicago Atlantic Real Estate Finance, Inc. (REFI) reported Q2 earnings of $0.43 per share, missing the Zacks Consensus Estimate of $0.48, and revenues of $12.84 million, also below the $13.85 million consensus. This marks an earnings surprise of -10.42% and a revenue miss of …

Ceragon Networks Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Ceragon Networks Ltd. reported its financial results for the second quarter and first six months of 2026. For the second quarter, sales increased to $93.91 million from $82.26 million year-over-year, but the company recorded a net loss of $2.09 million, higher than the $1.27 …

Mizuho Issues Positive Forecast for Trivago N.V. ADS (NASDAQ:TRVG) Stock Price

Mizuho has increased its price target for Trivago N.V. ADS (NASDAQ:TRVG) from $3.00 to $5.00, while maintaining a "neutral" rating, which still suggests a potential downside of 6.02% from the current price. Despite the upgrade, the consensus analyst rating for Trivago remains "Hold" with …

Mizuho raises trivago stock price target to $5 on revenue growth

Mizuho has increased its price target for trivago N.V. (NASDAQ:TRVG) to $5.00 from $3.00, maintaining a Neutral rating, following the company's sixth consecutive quarter of revenue growth and its first positive adjusted EBITDA for a seasonally low second quarter since 2023. Despite this positive …

Form 8K Chicago Atlantic Real Estate Finance Inc For: 11 August

This article announces that Chicago Atlantic Real Estate Finance Inc. filed a Form 8K on August 11. The brief piece indicates that Investing.com is the source and references the company's stock symbol REFI. No specific details of the 8K filing are provided within the …

Chicago Atlantic Real Estate Finance Announces Second Quarter 2026 Financial Results

Chicago Atlantic Real Estate Finance (NASDAQ: REFI) has released its second-quarter 2026 financial results, reporting $59.2 million in gross originations. While earnings were impacted by the timing of repayments and deployments, the company's portfolio continues to perform well. Chicago Atlantic also announced a significant …

Chicago Atlantic swaps stock for $62.5M notes secured by 32 cannabis properties

Chicago Atlantic Real Estate Finance (REFI) reported its Q2 2026 financial results, including net income of $7.5 million and distributable earnings of $9.3 million. The company exchanged 4.3 million shares for approximately $62.5 million in second-lien notes secured by 32 cannabis properties and is …

trivago (TRVG) insider Joana Breidenbach plans 733 ADS sale after option exercise

Trivago (TRVG) insider Joana Carena Breidenbach has filed a Form 144 notice to sell 733 American Depositary Shares (ADS) after exercising stock options. Each ADS represents five Class A shares. The filing also disclosed previous ADS sales by Breidenbach totaling 37,733 ADS in early …

Ceragon Networks (CRNT) grows Q2 2026 revenue 14% but posts GAAP loss

Ceragon Networks reported a 14.2% increase in Q2 2026 revenue, reaching $93.9 million, primarily driven by strong demand in India. Despite this growth, the company posted a GAAP net loss of $2.1 million, though it achieved a non-GAAP net income of $1.7 million. Management …

Chicago Atlantic Real Estate Finance (NASDAQ: REFI) posts Q2 update and merger details

Precious Dragon shareholders clear 2026 master supply deal

Chicago Atlantic Real Estate Finance, Inc. Q2 2026: Revenue $15.22M, EPS $0.34— 10-Q Summary

Chicago Atlantic Real Estate Finance, Inc. (REFI) reported its Q2 2026 results, showing revenue of $15.22M and diluted EPS of $0.34, both decreased from the prior year. Net income fell to $7.47M, largely due to lower exit/success fees and repricing in its portfolio of …

REFI: Q2 2026 net income dropped 16% and a merger with LIEN was announced, pending Q4 2026 close

Chicago Atlantic Real Estate Finance (REFI) reported a 16% year-over-year drop in Q2 2026 net income to $7.5M, attributed to lower interest income and higher CECL reserves. The company also declared a $0.47 per share dividend and announced a merger with Chicago Atlantic BDC, …

NetDragon Details Share Award Grant to Executive Director in Annual Report Update

Precious Dragon Sets Board Meeting to Approve Interim Results and Consider Dividend

Ceragon Networks Ltd (CRNT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Earnings To Watch: Chicago Atlantic Real Estate Finance Inc (REFI)

Chicago Atlantic Real Estate Finance Inc (REFI) is scheduled to release its Q2 2026 earnings on August 11, 2026, with revenue expected at $15.10 million and earnings at $0.44 per share. While 2026 estimates have slightly declined, 2027 estimates show an increase. Analysts have …

Patagonia Lithium Hits Promising Flows and Grades at Cilon Well 8

Agomab Therapeutics (AGMB) seeks two new directors, calls Sept. 11, 2026 shareholder meetings

Agomab Therapeutics (AGMB) has announced a special and extraordinary general shareholders' meeting for September 11, 2026, in Antwerp, Belgium. The company plans to propose the appointment of Marino Garcia and Dr. Naimish Patel as non-executive directors for four-year terms, subject to shareholder approval. Additionally, …

PTGX (PTGX) insider files to sell 225,000 shares under Rule 144

An insider at Protagonist Therapeutics (PTGX) has filed to sell 225,000 common shares under Rule 144, with an aggregate market value of $33,583,500. The sale will be executed through J.P. Morgan Securities LLC on Nasdaq and is associated with an option exercise. This filing …

Wedbush Adjusts PT on Protagonist Therapeutics to $173 From $118, Keeps Outperform Rating

Wedbush has increased its price target for Protagonist Therapeutics (PTGX) to $173 from $118, while maintaining an Outperform rating on the stock. This adjustment reflects a more optimistic outlook from the analyst firm.

Ceragon Networks Q2 2026 Earnings Preview

* Ceragon Networks (CRNT [https://seekingalpha.com/symbol/CRNT]) is scheduled to announce Q2 earnings results on Tuesday, August 11th, before market open. * The consensus EPS Estimate is $0.00 [https://seekingalpha.com/symbol/CRNT/earnings/estimates] (-100.0% Y/Y) and the consensus Revenue Estimate is $86.45M (+5.0% Y/Y). * Over the last 2 years, …

NHTSA Releases its Most Recent Installment of RV Recalls

The National Highway Traffic Safety Administration (NHTSA) has released its latest RV recall notices, affecting several manufacturers. Winnebago is recalling Ekko motorhomes for touchscreen issues that can unexpectedly activate generators, Brinkley RV is recalling Model I trailers due to improperly secured exterior ladders, and …

Protagonist upgraded at Goldman Sachs on potential of autoimmune asset

Goldman Sachs upgraded Protagonist Therapeutics (PTGX) to a buy rating from neutral, setting a price target of $186. The upgrade is driven by the promising potential of the company's phase 1 oral IL-17 antagonist, PN-881, which is being developed for various autoimmune conditions. This …

Goldman Sachs Upgrades Protagonist Therapeutics to Buy From Neutral, Adjusts PT to $186 From $110

Goldman Sachs has upgraded Protagonist Therapeutics (PTGX) to a "Buy" rating from "Neutral" and increased its price target to $186 from $110. The article also notes that Protagonist Therapeutics has an average rating of "Buy" and a mean price target of $159.36 from other …

Trivago NV (TRVG) files Form 144 for sale of 37,000 ADS

Trivago NV has filed a Form 144 notice for the proposed sale of 37,000 American Depositary Shares (ADS), each representing five Class A shares. The aggregate value of these ADS is $212,380, and the sale is scheduled for August 7, 2026. This transaction is …